← FDA Drug Approvals (Drugs@FDA)

CABTREO

NDA · New Drug Application · Sponsor: BAUSCH · Approved 2023-10-20

Drug application

FDA Application #

NDA216632

Application type

New Drug Application

Brand name

CABTREO

Generic name

CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE

Active ingredients

ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

BAUSCH

Manufacturer

Bausch Health US LLC

First approval

2023-10-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown